Byku Mirnela, Macarthur Heather, Westfall Thomas C
Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, 1402 S. Grand Blvd., St. Louis, MO 63104, USA.
Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2188-97. doi: 10.1152/ajpheart.00384.2008. Epub 2008 Oct 3.
The sympathetic nervous system and renin-angiotensin system are both thought to contribute to the development and maintenance of hypertension in experimental models such as the spontaneously hypertensive rat (SHR). We demonstrated that periarterial nerve stimulation (NS) increased the perfusion pressure (PP) and neuropeptide Y (NPY) overflow from perfused mesenteric arterial beds of SHRs at 4-6, 10-12, and 18-20 wk of age, which correspond to prehypertensive, developing hypertensive, and maintained hypertensive stages, respectively, in the SHR. NS also increased PP and NPY overflow from mesenteric beds of Wistar-Kyoto (WKY) normotensive rats. NS-induced increases in PP and NPY were greater in vessels obtained from SHRs of all three ages compared with WKY rats. ANG II produced a greater increase in PP in preparations taken from SHRs than WKY rats. ANG II also resulted in a greater increase in basal NPY overflow from 10- to 12-wk-old and 18- to 20-wk-old SHRs than age-matched WKY rats. ANG II enhanced the NS-induced overflow of NPY from SHR preparations more than WKY controls at all ages studied. The enhancement of NS-induced NPY overflow by ANG II was blocked by the AT1 receptor antagonist EMD-66684 and the angiotensin type 2 receptor antagonist PD-123319. In contrast, ANG II greatly enhanced norepinephrine overflow in the presence of PD-123319. Both captopril and EMD-66684 decreased neurotransmitter overflow from SHR mesenteric beds; therefore, we conclude that an endogenous renin-angiotensin system is active in this preparation. It is concluded that the ANG II-induced enhancement of sympathetic nerve stimulation may contribute to the development and maintenance of hypertension in the SHR.
在诸如自发性高血压大鼠(SHR)等实验模型中,交感神经系统和肾素 - 血管紧张素系统都被认为与高血压的发生和维持有关。我们证明,在SHR 4 - 6周、10 - 12周和18 - 20周龄时,动脉周围神经刺激(NS)会增加其灌注压(PP)以及灌流肠系膜动脉床中神经肽Y(NPY)的溢出,这三个阶段分别对应SHR的高血压前期、高血压发展期和高血压维持期。NS也会增加Wistar - Kyoto(WKY)正常血压大鼠肠系膜床的PP和NPY溢出。与WKY大鼠相比,NS诱导的PP和NPY增加在所有三个年龄段的SHR血管中都更大。与WKY大鼠相比,血管紧张素II(ANG II)使SHR制备物中的PP升高幅度更大。ANG II还导致10 - 12周龄和18 - 20周龄的SHR基础NPY溢出比年龄匹配的WKY大鼠增加更多。在所有研究的年龄段,ANG II比WKY对照组更能增强NS诱导的SHR制备物中NPY的溢出。ANG II对NS诱导的NPY溢出的增强作用被AT1受体拮抗剂EMD - 66684和2型血管紧张素受体拮抗剂PD - 123319阻断。相反,在存在PD - 123319的情况下,ANG II极大地增强了去甲肾上腺素的溢出。卡托普利和EMD - 66684都降低了SHR肠系膜床中神经递质的溢出;因此,我们得出结论,内源性肾素 - 血管紧张素系统在该制备物中是活跃的。得出的结论是,ANG II诱导的交感神经刺激增强可能有助于SHR高血压的发生和维持。